Press Releases

Date Title and Summary Additional Formats
Toggle Summary Chiltern and Medidata Mark 10-Year Anniversary Milestone in Bringing Cloud-based Technology to Clinical Development
WILMINGTON, N.C. & NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Chiltern , a leading global contract research organization (CRO), today announced an anniversary milestone in their strategic
View HTML
Toggle Summary UPDATED PRESENTATION DATE: Medidata to Present at Bank of America Merrill Lynch 2017 Global Technology Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann , chief financial officer, will present at the Bank of America Merrill Lynch 2017 Global Technology Conference on
View HTML
Toggle Summary Medidata to Present at Bank of America Merrill Lynch 2017 Global Technology Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann , chief financial officer, will present at the Bank of America Merrill Lynch 2017 Global Technology Conference on
View HTML
Toggle Summary Medidata to Present First-of-its-kind Scientific Innovation at 2017 ASCO Annual Meeting
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced its participation in the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting , the premier cancer-focused scientific
View HTML
Toggle Summary Medytox to Further Expand Global Presence by Increasing Its Adoption of the Medidata Clinical Cloud®
Global Biopharmaceutical Company to Become the First in Korea to Adopt Medidata's Risk-based Monitoring Solution for Its Major Clinical Trials Medytox Aims to Develop the Next Generation of Biomedicine through Improved Data Quality via Global Standards NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:
View HTML
Toggle Summary UPDATED PRESENTATION TIME FOR MAY 22: Medidata to Present at Upcoming Investor Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the company will present at the following upcoming investor conferences. Rouven Bergmann , chief financial officer, will present
View HTML
Toggle Summary Medidata's Julie Iskow Named a "Luminary" by the Healthcare Businesswomen's Association
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow has been named a 2017 "Luminary" by the Healthcare Businesswomen's Association (HBA).
View HTML
Toggle Summary Medidata Introduces Regulated Content and Document Management Capabilities to Its Industry-Leading Cloud Platform
Medidata's Regulated Content Management Solution Leverages Box Platform to Create the Only Content Integrity and Collaboration Platform for Both Regulated and Nonregulated Content NEW YORK --(BUSINESS WIRE)-- On the heels of its recent acquisition of CHITA , Medidata (NASDAQ:MDSO), the leading
View HTML
Toggle Summary Medidata to Present at Upcoming Investor Conferences
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the company will present at the following upcoming investor conferences. Rouven Bergmann , chief financial officer, will present
View HTML
Toggle Summary Medidata Reports Record First Quarter 2017 Results
Record revenue of $126.8 million , representing 22% year-over-year growth GAAP net income of $9.5 million , or $0.16 per diluted share, up 108% year-over-year Cash flow from operations of $22.5 million , representing 63% year-over-year growth NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the
View HTML

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com